Latest update
SurgeMonitoring onlyWill AbbVie Q3 Global Skyrizi net revenues be above $5.5B? — probability rises to 60%
The tracked probability rose to 60%, up 14.0 percentage points from 46% in the latest observation window. No evidence-qualified public source was supplied, so this remains a monitoring note rather than a causal explanation.
Yes: 46% → 60%
+14.0 pp